Postoperative adjuvant TACE for patients of hepatocellular carcinoma in AJCC stage I: friend or foe? a propensity score analysis

BACKGROUND: Although the transcatheter arterial chemoembolization (TACE) was demonstrated to be an alternative treatment of hepatocellular carcinoma with favorable oncological effect, the benefit of postoperative adjuvant TACE was still controversial. The aim of this study was to evaluate the effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Yifan, Li, Zheyong, Liang, Yuelong, Yu, Hong, Liang, Xiao, Liu, Hui, Cai, Xiujun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432288/
https://www.ncbi.nlm.nih.gov/pubmed/28460456
http://dx.doi.org/10.18632/oncotarget.15793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432288/
https://www.ncbi.nlm.nih.gov/pubmed/28460456
http://dx.doi.org/10.18632/oncotarget.15793

Ejemplares similares